Novelix Pharmaceuticals Ltd — Insider Trading, 01-06-2026: Insider Trading / SAST

Novelix Pharmaceuticals has announced a board meeting to discuss a proposal for fund raising. The company is considering issuing permissible securities through a preferential issue or other modes. In connection with this upcoming meeting, the trading window for designated persons and their relatives is now closed. It will reopen 48 hours after the meeting's outcome is publicly disclosed. This move signals potential capital infusion for the company's future plans and growth initiatives.